Page last updated: 2024-08-24

imiquimod and Armstrong Syndrome

imiquimod has been researched along with Armstrong Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alflen, A; Denny, M; Hartmann, AK; Langguth, P; Lopez, PA; Probst, HC; Radsak, MP; Schild, H; Stassen, M; Tenzer, S; von Stebut, E	1

Other Studies

1 other study(ies) available for imiquimod and Armstrong Syndrome

Article	Year
Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection. Journal of dermatological science, 2017, Volume: 87, Issue:3 Topics: Administration, Cutaneous; Aminoquinolines; Animals; Cell Movement; Disease Models, Animal; Emulsions; Epitopes; Flow Cytometry; Humans; Imiquimod; Langerhans Cells; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Major Histocompatibility Complex; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Signal Transduction; Skin; Skin Neoplasms; T-Lymphocytes, Cytotoxic; Toll-Like Receptor 7; Vaccination	2017

Article

Year

Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection.

Journal of dermatological science, 2017, Volume: 87, Issue:3

Topics: Administration, Cutaneous; Aminoquinolines; Animals; Cell Movement; Disease Models, Animal; Emulsions; Epitopes; Flow Cytometry; Humans; Imiquimod; Langerhans Cells; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Major Histocompatibility Complex; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Signal Transduction; Skin; Skin Neoplasms; T-Lymphocytes, Cytotoxic; Toll-Like Receptor 7; Vaccination

2017